Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Autoimmune Disorders

  Free Subscription


Articles published in J Nephrol

Retrieve available abstracts of 120 articles:
HTML format



Single Articles


    January 2025
  1. KANG D, Zhang M, Chen Z, Zheng Z, et al
    Clinicopathological characteristics and prognosis of lupus nephritis patients with positive anti-ribonucleoprotein antibodies.
    J Nephrol. 2025 Jan 20. doi: 10.1007/s40620-024-02177.
    PubMed     Abstract available


    December 2024
  2. JAFRY NH, Butt N, Mubarak M, Akhtar SF, et al
    Anti-glomerular basement membrane disease complicated by malaria during pregnancy with successful maternal and fetal outcomes: a case report.
    J Nephrol. 2024;37:2655-2660.
    PubMed     Abstract available


    November 2024
  3. YANG M, Liu X, Chen Y, Chen X, et al
    Validation and modification of renal risk score for prediction of long-term kidney survival in patients with MPO-ANCA-associated glomerulonephritis.
    J Nephrol. 2024 Nov 22. doi: 10.1007/s40620-024-02134.
    PubMed     Abstract available


  4. KANBAY M, Ozbek L, Guldan M, Copur S, et al
    Post-transplant IgA nephropathy: a rapidly evolving field of kidney transplant medicine.
    J Nephrol. 2024 Nov 20. doi: 10.1007/s40620-024-02149.
    PubMed     Abstract available


  5. QUEYREL-MORANNE V, Daniel L, Moranne O
    Focal segmental glomerulosclerosis in a native African patient with systemic lupus erythematosus.
    J Nephrol. 2024 Nov 12. doi: 10.1007/s40620-024-02106.
    PubMed    


    October 2024
  6. ELAHI T, Ahmed S, Ahmed E, Mubarak M, et al
    Clinicopathological characteristics and outcomes of adult patients with idiopathic membranoproliferative glomerulonephritis according to an immunofluorescence-based classification.
    J Nephrol. 2024 Oct 14. doi: 10.1007/s40620-024-02083.
    PubMed     Abstract available


  7. ZHANG Q, Zhou F, Zhao Y, Luo C, et al
    The uncertain correlation of ANCAs in patients with lupus nephritis and crescents, an experience from Chinese centers.
    J Nephrol. 2024 Oct 10. doi: 10.1007/s40620-024-02085.
    PubMed     Abstract available


  8. BARAGETTI I, Del Vecchio L, Ferrario F, Alberici F, et al
    The safety of corticosteroid therapy in IGA nephropathy: analysis of a real-life Italian cohort.
    J Nephrol. 2024 Oct 6. doi: 10.1007/s40620-024-02071.
    PubMed     Abstract available


  9. HERNANDEZ-ANDRADE A, Nordmann-Gomes A, Juarez-Cuevas B, Zavala-Miranda MF, et al
    Urine epidermal growth factor as a biomarker for kidney function recovery and prognosis in glomerulonephritis with severe kidney function impairment.
    J Nephrol. 2024 Oct 4. doi: 10.1007/s40620-024-02068.
    PubMed     Abstract available


    July 2024
  10. YANG T, Shi Y, Wang Y, Feng Y, et al
    Hydroxychloroquine blood concentrations and effects in Chinese patients with IgA nephropathy.
    J Nephrol. 2024 Jul 24. doi: 10.1007/s40620-024-02029.
    PubMed     Abstract available


  11. BALTU D, Serin O, Aksu T, Hizarcioglu Gulsen H, et al
    Membranoproliferative glomerulonephritis in a patient with lysinuric protein intolerance: lesson for the clinical nephrologist.
    J Nephrol. 2024 Jul 17. doi: 10.1007/s40620-024-02018.
    PubMed    


  12. PERNA A, Campise M, Alfieri CM, Regalia A, et al
    Kidney transplantation in patients with ANCA-associated vasculitis is associated with a high incidence of post-transplant cancer.
    J Nephrol. 2024;37:1611-1619.
    PubMed     Abstract available


    June 2024
  13. SARA M, Anna S, Lorenzo B, Valentina B, et al
    Macrophage activation syndrome secondary to systemic lupus erythematosus: lesson for the clinical nephrologist.
    J Nephrol. 2024 Jun 28. doi: 10.1007/s40620-024-01997.
    PubMed    


  14. RATNAYAKE C, Crombie T, Fraenkel M, McMahon LP, et al
    Haemoptysis in a stable kidney transplant patient previously seropositive for anti-GBM and ANCA glomerulonephritis.
    J Nephrol. 2024 Jun 18. doi: 10.1007/s40620-024-01993.
    PubMed    


  15. LIM RS, Yeo SC
    EXternal validation of international IgA nephropathy prediction tool in a Singapore CohorT (EXIST Study).
    J Nephrol. 2024 Jun 13. doi: 10.1007/s40620-024-01985.
    PubMed    


  16. LIU L, de Leeuw K, der Meer BD, van Goor H, et al
    Expression of myxovirus resistance protein A in lupus nephritis and other glomerular nephropathies.
    J Nephrol. 2024 Jun 5. doi: 10.1007/s40620-024-01971.
    PubMed    


  17. CUGNO M, Mancuso MC, Depetri F, Peyvandi F, et al
    IgM autoantibodies to complement factor H in C3 glomerulopathy.
    J Nephrol. 2024 Jun 1. doi: 10.1007/s40620-024-01961.
    PubMed    


    May 2024
  18. NAGARAJAH S, Saleh QW, Rasmussen M, Tepel M, et al
    Long non-coding RNA MGAT3 in kidney transplant recipients with immunoglobulin A nephropathy.
    J Nephrol. 2024;37:1133-1135.
    PubMed    


  19. CETINKAYA H, Gursu M, Yazici H, Cebeci E, et al
    Could mesangial C3 deposition be an independent prognostic marker in immunoglobulin A nephropathy?
    J Nephrol. 2024;37:923-932.
    PubMed     Abstract available


    April 2024
  20. DAVIES E, Chetwynd A, McDowell G, Rao A, et al
    The current use of proteomics and metabolomics in glomerulonephritis: a systematic literature review.
    J Nephrol. 2024 Apr 30. doi: 10.1007/s40620-024-01923.
    PubMed     Abstract available


  21. SHAHEEN M, Bharat A, Friedman AN, Guo S, et al
    ALECT2 amyloidosis with concurrent IgG4-related interstitial nephritis, membranous nephropathy and diabetic kidney disease: a case report and literature review.
    J Nephrol. 2024 Apr 17. doi: 10.1007/s40620-024-01924.
    PubMed     Abstract available


    March 2024
  22. ROBERT JT, Rajaram A, Fiset PO, Bernard C, et al
    Class V lupus nephritis recurrence with histologic resolution in a kidney transplant recipient on a pregnancy-adapted immunosuppression protocol: a lesson for the clinical nephrologist.
    J Nephrol. 2024 Mar 26. doi: 10.1007/s40620-024-01920.
    PubMed    


  23. HU D, Wang Z, Wang S, Li Y, et al
    Lymphatic vessels in patients with crescentic glomerulonephritis: association with renal pathology and prognosis.
    J Nephrol. 2024 Mar 25. doi: 10.1007/s40620-024-01903.
    PubMed     Abstract available


  24. REN W, Sun J, Zhang L, He W, et al
    Significance of the total renal chronicity score in predicting renal outcome in PLA2R-associated membranous nephropathy.
    J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-024-01893.
    PubMed     Abstract available


  25. ARNAERT S, Schepens N, Deleu L, Malfait T, et al
    Case report: renal recovery in Goodpasture's syndrome treated with rituximab.
    J Nephrol. 2024 Mar 1. doi: 10.1007/s40620-024-01892.
    PubMed     Abstract available


  26. VAZ DE CASTRO PAS, Amaral AA, Almeida MG, Selvaskandan H, et al
    Examining the association between serum galactose-deficient IgA1 and primary IgA nephropathy: a systematic review and meta-analysis.
    J Nephrol. 2024 Mar 1. doi: 10.1007/s40620-023-01874.
    PubMed     Abstract available


    February 2024
  27. CHRISTODOULOU M, Moysidou E, Lioulios G, Stai S, et al
    The prognostic value of two histopathologic classification models of ANCA-associated glomerulonephritis: a prospective study.
    J Nephrol. 2024 Feb 12. doi: 10.1007/s40620-023-01855.
    PubMed     Abstract available


  28. OCHIAI S, Kikuchi M, Kaikita K, Fujimoto S, et al
    Rapidly progressive glomerulonephritis due to IgA nephropathy accompanied by collagenofibrotic glomerulopathy. A nephrology picture.
    J Nephrol. 2024 Feb 6. doi: 10.1007/s40620-023-01875.
    PubMed    


    January 2024
  29. TRIMARCHI H, Fervenza FC, Coppo R
    Points of view in nephrology: personalized management of IgA nephropathy, beyond KDIGO.
    J Nephrol. 2024 Jan 18. doi: 10.1007/s40620-023-01833.
    PubMed     Abstract available


  30. HE WJ, Wang J, Liu N, Li GY, et al
    The efficacy and safety of hydroxychloroquine versus leflunomide in patients with IgA nephropathy: a single-center experience.
    J Nephrol. 2024 Jan 16. doi: 10.1007/s40620-023-01839.
    PubMed     Abstract available


    December 2023
  31. SCHENA FP, Cox SN
    Correction to: Is it time for personalized therapy in IgA nephropathy patients?
    J Nephrol. 2023 Dec 8. doi: 10.1007/s40620-023-01861.
    PubMed    


  32. BOUSSETTA A, Jellouli M, Hajji M, Rekaya S, et al
    A membranous nephropathy in a 5 year-old boy: and if that's not all? A nephrology quiz.
    J Nephrol. 2023 Dec 6. doi: 10.1007/s40620-023-01821.
    PubMed    


    November 2023
  33. ALBERTAZZI V, Fontana F, Giberti S, Aiello V, et al
    Primary membranous nephropathy in the Italian region of Emilia Romagna: results of a multicenter study with extended follow-up.
    J Nephrol. 2023 Nov 13. doi: 10.1007/s40620-023-01803.
    PubMed     Abstract available


  34. BANJONGJIT A, Thammathiwat T, Townamchai N, Kanjanabuch T, et al
    SARS-CoV-2 infection associated with antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (ANCA-GN): a systematic review and two case reports.
    J Nephrol. 2023 Nov 6. doi: 10.1007/s40620-023-01777.
    PubMed     Abstract available


  35. RUSSWURM M, Kortus-Goetze B, Maier-Giebing T, Groene HJ, et al
    General prognostic models may neglect vulnerable subgroups in ANCA-associated vasculitis.
    J Nephrol. 2023;36:2269-2280.
    PubMed     Abstract available


  36. GOTO K, Imaizumi T, Hamada R, Ishikura K, et al
    Renal pathology in adult and paediatric population of Japan: review of the Japan renal biopsy registry database from 2007 to 2017.
    J Nephrol. 2023;36:2257-2267.
    PubMed     Abstract available


  37. XIONG L, Liu L, Tao Y, Guo H, et al
    Clinical significance of IgM and C3 deposition in children with primary immunoglobulin A nephropathy.
    J Nephrol. 2023;36:2213-2222.
    PubMed     Abstract available


  38. RAO IR, Kolakemar A, Shenoy SV, Prabhu RA, et al
    Hydroxychloroquine in nephrology: current status and future directions.
    J Nephrol. 2023;36:2191-2208.
    PubMed     Abstract available


  39. SCURT FG, Hirschfeld V, Ganz M, Mertens PR, et al
    Low levels of complement factor C3 at diagnosis can predict outcome in antineutrophil antibody associated vasculitis.
    J Nephrol. 2023;36:2281-2293.
    PubMed     Abstract available


  40. WANG F, Jin Y, Zhou F, Luo L, et al
    Urinary isomorphic red blood cells for the prediction of disease severity and renal outcomes in MPO-ANCA-associated vasculitis: a retrospective cohort study.
    J Nephrol. 2023;36:2295-2304.
    PubMed     Abstract available


  41. ROCCATELLO D, Careddu A, Ferro M, Naretto C, et al
    The steroid-sparing effects of a mycophenolate mofetil-based regimen in the management of immunoglobulin A nephropathy in patients with histologically active lesions: A comparison with a control cohort receiving conventional therapy.
    J Nephrol. 2023;36:2223-2231.
    PubMed     Abstract available


  42. ALVAREZ L, Kambham N, Su R
    Renal improvement and remission in a patient with refractory ANCA-associated vasculitis treated with avacopan.
    J Nephrol. 2023;36:2365-2370.
    PubMed     Abstract available


    October 2023
  43. LIU Z, Wan C, Cao Y, Liu S, et al
    Distribution spectrum and clinical significance of glomerular exostosin (EXT1) deposits in PLA2R-positive membranous nephropathy.
    J Nephrol. 2023 Oct 26. doi: 10.1007/s40620-023-01779.
    PubMed     Abstract available


  44. PALA C, Parenti E, Vizzini G, Gianfreda D, et al
    Thrombotic microangiopathy due to primary antiphospholipid syndrome: successful treatment with eculizumab.
    J Nephrol. 2023 Oct 17. doi: 10.1007/s40620-023-01789.
    PubMed     Abstract available


  45. MONGERA N, Passler W, Sethi S, Kozakowski N, et al
    A case of protocadherin FAT1-positive membranous nephropathy secondary to hematopoietic stem-cell transplantation.
    J Nephrol. 2023 Oct 10. doi: 10.1007/s40620-023-01786.
    PubMed    


    September 2023
  46. PAOLO SF, Natasha CS
    Is it time for personalized therapy in IgA nephropathy patients?
    J Nephrol. 2023 Sep 22. doi: 10.1007/s40620-023-01745.
    PubMed    


  47. AI S, Yan X, Zhao X, Ye W, et al
    Malignancy-associated membranous nephropathy: focus on diagnosis and treatment.
    J Nephrol. 2023 Sep 15. doi: 10.1007/s40620-023-01751.
    PubMed     Abstract available


  48. BAIER E, Kluge IA, Hakroush S, Tampe B, et al
    Low hemoglobin levels are associated with Bowman's capsule rupture and peritubular capillaritis in ANCA-associated renal vasculitis: a link of vascular injury to anemia?
    J Nephrol. 2023 Sep 7. doi: 10.1007/s40620-023-01748.
    PubMed     Abstract available


  49. DIRIM AB, Agargun BF, Hurdogan O, Ozluk Y, et al
    Two cases of IgA nephropathy after splenectomy: spleen as a silent culprit in the pathogenesis of IgA nephropathy.
    J Nephrol. 2023 Sep 4. doi: 10.1007/s40620-023-01764.
    PubMed    


    August 2023
  50. TERINTE-BALCAN G, Stancu S, Zugravu A, Capusa C, et al
    Prognostic role of glomerular electron microscopy lesions in IgA nephropathy: "the devil is in the details".
    J Nephrol. 2023 Aug 26. doi: 10.1007/s40620-023-01744.
    PubMed     Abstract available


  51. CEOL M, Gianesello L, Trimarchi H, Migliorini A, et al
    Human parietal epithelial cells (PECs) and proteinuria in lupus nephritis: a role for ClC-5, megalin, and cubilin?
    J Nephrol. 2023 Aug 18. doi: 10.1007/s40620-023-01725.
    PubMed     Abstract available


    July 2023
  52. LU H, Li Y, Lai M, Guan T, et al
    Clinicopathologic features and long-term prognosis of hepatitis B virus-associated glomerulonephritis: a retrospective cohort study.
    J Nephrol. 2023 Jul 31. doi: 10.1007/s40620-023-01685.
    PubMed     Abstract available


  53. VASURI F, Lisi AP, Ciavarella C, Degiovanni A, et al
    Caveolin-1 in situ expression in glomerular and peritubular capillaries as a marker of ultrastructural progression and severity of renal thrombotic microangiopathy.
    J Nephrol. 2023 Jul 22. doi: 10.1007/s40620-023-01645.
    PubMed     Abstract available


  54. KOBAYASHI H, Satake E, Murata Y, Otsuka H, et al
    Neuroblastoma suppressor of tumorigenicity 1 is associated with the severity of interstitial fibrosis and kidney function decline in IgA nephropathy.
    J Nephrol. 2023 Jul 12. doi: 10.1007/s40620-023-01704.
    PubMed     Abstract available


    June 2023
  55. WATANABE H, Yamana H, Okada A, Matsui H, et al
    Therapeutic plasma exchange for anti-glomerular basement membrane disease with dialysis-dependent kidney failure without diffuse alveolar hemorrhage.
    J Nephrol. 2023 Jun 24. doi: 10.1007/s40620-023-01695.
    PubMed     Abstract available


  56. JANKOWSKI E, Schlosser M, Wiech T, Wolf G, et al
    SARS-CoV-2 infection: a possible trigger for the recurrence of IgA nephropathy after kidney transplantation?
    J Nephrol. 2023 Jun 21. doi: 10.1007/s40620-023-01684.
    PubMed     Abstract available


  57. FAN Y, Kang D, Chen Z, Lu Y, et al
    Clinicopathological characteristics and outcomes of lupus nephritis patients with scanty immune depositions in kidney biopsies.
    J Nephrol. 2023 Jun 21. doi: 10.1007/s40620-023-01622.
    PubMed     Abstract available


  58. ZAPPI S, Bernasconi L, Fischer I, Hoxha E, et al
    Lesson for the clinical nephrologist: thrombospondin type-1 domain-containing protein 7A-associated membranous nephropathy and Fanconi syndrome in a patient with a squamous cell lung cancer.
    J Nephrol. 2023 Jun 9. doi: 10.1007/s40620-023-01630.
    PubMed    


  59. ZHANG L, Du M, Tu Y, Liang D, et al
    Clinicopathological features and long-term prognosis of glomerular diseases associated with mercury-containing cosmetics.
    J Nephrol. 2023;36:1401-1407.
    PubMed     Abstract available


    May 2023
  60. WEHRMANN F, von Bergwelt-Baildon A, Schonermarck U
    Severe hypertension and (renal) thrombotic microangiopathy: solving the puzzle.
    J Nephrol. 2023 May 31. doi: 10.1007/s40620-023-01659.
    PubMed    


  61. AGRAWAL A, Chong GY, Fidler ME, Cramer Ii CH, et al
    Early post-transplant recurrence of ANCA vasculitis while on belatacept maintenance immunosuppression.
    J Nephrol. 2023;36:1169-1174.
    PubMed     Abstract available


    April 2023
  62. SOMA Y, Kato M, Shimura G, Kamio M, et al
    Renal biopsy diagnosis of IgG4-related kidney disease with minor hematuria and mild renal dysfunction: lessons for the clinical nephrologist.
    J Nephrol. 2023;36:639-642.
    PubMed    


  63. ZHU M, Wang J, Le W, Xu F, et al
    Relationship between anti-GBM antibodies and kidney outcomes in patients with anti-GBM disease.
    J Nephrol. 2023;36:789-797.
    PubMed     Abstract available


    March 2023
  64. LACETERA R, Calatroni M, Roggero L, Radice A, et al
    Prevalence and clinical significance of ANCA positivity in lupus nephritis: a case series of 116 patients and literature review.
    J Nephrol. 2023 Mar 20. doi: 10.1007/s40620-023-01574.
    PubMed     Abstract available


  65. LI JP, Du YT, Guo C, Rao XR, et al
    IgA nephropathy to proliferative glomerulonephritis with monoclonal IgAkappa deposits: a pattern switch.
    J Nephrol. 2023 Mar 13. doi: 10.1007/s40620-023-01583.
    PubMed     Abstract available


  66. HE G, Tao L, Li C, Zhong X, et al
    The spectrum and changes of biopsy-proven kidney diseases in Chinese children.
    J Nephrol. 2023;36:417-427.
    PubMed     Abstract available


    February 2023
  67. RONSIN C, Jacquemont L, Testa A, Renaudin K, et al
    ANCA-negative pauci-immune crescentic glomerulonephritis associated with Fabry disease: lesson for the clinical nephrologist.
    J Nephrol. 2023 Feb 16. doi: 10.1007/s40620-022-01533.
    PubMed    


  68. FONTANA F, Delsante M, Vicari M, Pala C, et al
    Mycophenolate mofetil plus steroids compared to steroids alone in IgA nephropathy: a retrospective study.
    J Nephrol. 2023 Feb 15. doi: 10.1007/s40620-023-01578.
    PubMed    


  69. SU X, Song R, Li S, Guo W, et al
    Outcomes and risk factors in patients with crescentic glomerulonephritis: a multicenter cohort study.
    J Nephrol. 2023 Feb 14. doi: 10.1007/s40620-022-01550.
    PubMed     Abstract available


    January 2023
  70. VILLEGAS-GAMAS JM, Marquez-Macedo SE, Jimenez-Franco B, Fonseca-Correa JI, et al
    Proliferative glomerulonephritis with monoclonal IgG deposits triggered by Filgrastim in a patient with multiple myeloma.
    J Nephrol. 2023 Jan 18. doi: 10.1007/s40620-022-01555.
    PubMed    


  71. LIE DNW, Chan KW, Tang AHN, Chan ATP, et al
    Long-term outcomes of add-on direct renin inhibition in igA nephropathy: a propensity score-matched cohort study.
    J Nephrol. 2023 Jan 11. doi: 10.1007/s40620-022-01530.
    PubMed     Abstract available


  72. TANAKA M, Moniwa N, Nogi C, Kano T, et al
    Glomerular expression and urinary excretion of fatty acid-binding protein 4 in IgA nephropathy.
    J Nephrol. 2023 Jan 9. doi: 10.1007/s40620-022-01551.
    PubMed     Abstract available


    December 2022
  73. HE L, Wang H, He P, Jiang Y, et al
    Serum Long Noncoding RNA H19 and CKD Progression in IgA Nephropathy.
    J Nephrol. 2022 Dec 27. doi: 10.1007/s40620-022-01536.
    PubMed     Abstract available


  74. BAIER E, Kluge IA, Hakroush S, Tampe D, et al
    Leukocyturia and hematuria enable non-invasive differentiation of Bowman's capsule rupture severity in PR3-ANCA glomerulonephritis.
    J Nephrol. 2022 Dec 21. doi: 10.1007/s40620-022-01486.
    PubMed     Abstract available


  75. HUANG Z, Hu Y, Chen B, Liang Y, et al
    Clinical significance of intrarenal vascular lesions in non-hypertensive patients with IgA nephropathy.
    J Nephrol. 2022 Dec 20. doi: 10.1007/s40620-022-01511.
    PubMed     Abstract available


  76. KADEMANI SP, Nelaturi P, Sathyasagar K, Ravikumar S, et al
    Noncoding RNAs associated with IgA nephropathy.
    J Nephrol. 2022 Dec 10. doi: 10.1007/s40620-022-01498.
    PubMed     Abstract available


  77. ALLINOVI M, Lugli G, Rossi F, Palterer B, et al
    Accuracy of serum PLA2R antibody detected by indirect immunofluorescence in diagnosing biopsy-proven primary membranous nephropathy: a single-center experience and a systematic review of the literature.
    J Nephrol. 2022 Dec 3. doi: 10.1007/s40620-022-01528.
    PubMed    


  78. POPA O, Capusa C, Stefan G, Mandache E, et al
    How useful is kidney biopsy for the management of glomerulopathies in the elderly?
    J Nephrol. 2022;35:2301-2312.
    PubMed     Abstract available


  79. MOGUEL GONZALEZ B, Garcia Nava M, Orozco Guillen OA, Soto Abraham V, et al
    Kidney biopsy during pregnancy: a difficult decision. A case series reporting on 20 patients from Mexico.
    J Nephrol. 2022;35:2293-2300.
    PubMed     Abstract available


    November 2022
  80. STAI S, Lioulios G, Christodoulou M, Papagianni A, et al
    From KDIGO 2012 towards KDIGO 2021 in idiopathic membranous nephropathy guidelines: what has changed over the last 10 years?
    J Nephrol. 2022 Nov 30. doi: 10.1007/s40620-022-01493.
    PubMed     Abstract available


  81. GREVE AS, Prakash S, Krag S, Randers E, et al
    Focal segmental glomerulosclerosis in a patient with multiple sclerosis treated with Teriflunomide and Ocrelizumab.
    J Nephrol. 2022 Nov 21. doi: 10.1007/s40620-022-01504.
    PubMed     Abstract available


    October 2022
  82. SCHENA FP, Anelli VW, Di Noia T, Tripepi G, et al
    Post-hoc analysis of a tool to predict kidney failure in patients with IgA nephropathy.
    J Nephrol. 2022 Oct 21. pii: 10.1007/s40620-022-01463.
    PubMed     Abstract available


  83. CLAUDIO P
    Primary membranous nephropathy: an endless story.
    J Nephrol. 2022 Oct 17. pii: 10.1007/s40620-022-01461.
    PubMed     Abstract available


  84. DE SOUZA L, Ismail I, Baade R, Mantha M, et al
    Lessons for the clinical nephrologist: dialysis decisions in early pregnancy for acute kidney injury due to post-infectious glomerulonephritis (PIGN).
    J Nephrol. 2022 Oct 14. pii: 10.1007/s40620-022-01464.
    PubMed    


  85. CHBIHI M, Eveillard LA, Riller Q, Brousse R, et al
    Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus Cyclophosphamide.
    J Nephrol. 2022 Oct 8. pii: 10.1007/s40620-022-01438.
    PubMed     Abstract available


    September 2022
  86. SEIKRIT C, Schimpf JI, Wied S, Stamellou E, et al
    Intestinal permeability in patients with IgA nephropathy and other glomerular diseases: an observational study.
    J Nephrol. 2022 Sep 15. pii: 10.1007/s40620-022-01454.
    PubMed     Abstract available


  87. XU L, Kant S, Aqeel F, Antiochos B, et al
    Urinary cell mRNA profiling distinguishes disease activity in antineutrophil cytoplasmic antibody-associated glomerulonephritis.
    J Nephrol. 2022 Sep 9. pii: 10.1007/s40620-022-01460.
    PubMed    


    August 2022
  88. TAMPE D, Baier E, Hakroush S, Tampe B, et al
    Comparative analysis of complement C3 and C4 serum levels for outcome prediction in ANCA-associated renal vasculitis.
    J Nephrol. 2022 Aug 13. pii: 10.1007/s40620-022-01414.
    PubMed     Abstract available


  89. STEFAN G, Zugravu A, Stancu S
    Intravenous cyclophosphamide as an alternative to the oral cyclophosphamide modified Ponticelli regimen for high-risk PLA2R-positive membranous nephropathy.
    J Nephrol. 2022 Aug 12. pii: 10.1007/s40620-022-01426.
    PubMed    


    July 2022
  90. WU Q, Liang D, Song T, Ni X, et al
    Poor outcomes of proliferative glomerulonephritis with monoclonal IgG deposits in renal allografts: a retrospective multicenter study.
    J Nephrol. 2022 Jul 22. pii: 10.1007/s40620-022-01385.
    PubMed     Abstract available


  91. XIE M, Zhu Y, Wang X, Ren J, et al
    Predictive prognostic value of glomerular C3 deposition in IgA nephropathy.
    J Nephrol. 2022 Jul 4. pii: 10.1007/s40620-022-01363.
    PubMed     Abstract available


    May 2022
  92. PICCOLI GB
    The heritage of Thomas Addis: why do nephrologists still love glomerulonephritis?
    J Nephrol. 2022 May 11. pii: 10.1007/s40620-022-01343.
    PubMed    


  93. OKI R, Unagami K, Taneda S, Takagi T, et al
    Treatment with bortezomib for recurrent proliferative glomerulonephritis with monoclonal IgG deposits in kidney allograft. Case report and review of the literature.
    J Nephrol. 2022 May 6. pii: 10.1007/s40620-022-01332.
    PubMed     Abstract available


  94. TAMPE D, Hakroush S, Biggemann L, Winkler MS, et al
    Kinetics of human leukocyte antigen receptor HLA-DR(+) monocytes and T lymphocytes during remission induction therapy in ANCA-associated vasculitis.
    J Nephrol. 2022;35:1283-1287.
    PubMed     Abstract available


  95. TESAR V, Hruskova Z
    Extrarenal complications of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) and their impact on the outcome of the patients.
    J Nephrol. 2022;35:1065-1068.
    PubMed    


  96. MAKATI D, Akers J, Aljuhani M, Pellegrino B, et al
    Prevalence of ANCA-associated vasculitis amid natural gas drilling sites in West Virginia.
    J Nephrol. 2022;35:1185-1192.
    PubMed     Abstract available


    April 2022
  97. LIU M, Yu X, Wang S, Qin A, et al
    Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: an entity associated with distinct diseases and comparison between IgG1 and IgG3 subtypes.
    J Nephrol. 2022 Apr 23. pii: 10.1007/s40620-022-01317.
    PubMed     Abstract available


  98. DUAN T, Zhu X, Zhao Q, Xiao L, et al
    Association of Bowman's capsule rupture with prognosis in patients with lupus nephritis.
    J Nephrol. 2022 Apr 18. pii: 10.1007/s40620-022-01316.
    PubMed     Abstract available


  99. HAKROUSH S, Kluge IA, Baier E, Korsten P, et al
    pANCA autoantibody testing by indirect immunofluorescence indicates interstitial arteritis independent of MPO-ANCA immunoassays in ANCA-associated glomerulonephritis.
    J Nephrol. 2022 Apr 5. pii: 10.1007/s40620-022-01320.
    PubMed    


    March 2022
  100. RUAN Y, Hong F, Wu J, Lin M, et al
    Clinicopathological characteristics, risk factors and renal outcome in IgA nephropathy with crescents.
    J Nephrol. 2022 Mar 15. pii: 10.1007/s40620-022-01273.
    PubMed     Abstract available


  101. DEL VECCHIO L, Locatelli F, Ponticelli C
    The treatment of membranous nephropathy: a journey in the search for evidence.
    J Nephrol. 2022 Mar 1. pii: 10.1007/s40620-022-01291.
    PubMed    


  102. REZAC J, Honsova E, Masek M, Rysava R, et al
    Granulomatosis with polyangiitis mimicking cancer: a diagnostic dilemma.
    J Nephrol. 2022;35:675-678.
    PubMed    


    February 2022
  103. FAUCON AL, Cereja S, Mussini C, Goujon JM, et al
    Filgrastim-induced recurrent macroscopic hematuria in a patient with DNAJB9 positive fibrillary glomerulonephritis.
    J Nephrol. 2022 Feb 24. pii: 10.1007/s40620-022-01278.
    PubMed    


  104. BOSE B, Chung EYM, Hong R, Strippoli GFM, et al
    Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis.
    J Nephrol. 2022 Feb 23. pii: 10.1007/s40620-022-01268.
    PubMed     Abstract available


    December 2021
  105. HAKROUSH S, Tampe B
    Neutrophils associate with Bowman's capsule rupture specifically in PR3-ANCA glomerulonephritis.
    J Nephrol. 2021 Dec 1. pii: 10.1007/s40620-021-01208.
    PubMed     Abstract available


  106. WANG K, Yu Z, Huang Y, Yang K, et al
    Clinicopathological features, risk factors, and outcomes of immunoglobulin A nephropathy associated with hepatitis B virus infection.
    J Nephrol. 2021;34:1887-1896.
    PubMed     Abstract available


    November 2021
  107. CHENG YJ, Cheng XY, Zhang YM, Wang F, et al
    Effects of hydroxychloroquine on proteinuria in membranous nephropathy.
    J Nephrol. 2021 Nov 30. pii: 10.1007/s40620-021-01182.
    PubMed     Abstract available


  108. CALISKAN Y, Demir E, Karatay E, Ozluk Y, et al
    Oxidative stress and macrophage infiltration in IgA nephropathy.
    J Nephrol. 2021 Nov 16. pii: 10.1007/s40620-021-01196.
    PubMed     Abstract available


  109. MANENTI L, Rossi GM, Pisani I, Gentile M, et al
    IgA nephropathy and atypical hemolytic uremic syndrome: a case series and a literature review.
    J Nephrol. 2021 Nov 10. pii: 10.1007/s40620-021-01189.
    PubMed     Abstract available


  110. HAKROUSH S, Gersmann AK, Tampe B
    Histopathological and ultrastructural monitoring of remission induction in crescentic C3 glomerulonephritis.
    J Nephrol. 2021 Nov 6. pii: 10.1007/s40620-021-01169.
    PubMed    


    October 2021
  111. GUO Y, Shi S, Zhou X, Liu L, et al
    The effect of immunosuppressive therapy in patients with fibrinoid necrosis lesions in a large cohort of patients with IgA nephropathy.
    J Nephrol. 2021 Oct 21. pii: 10.1007/s40620-021-01176.
    PubMed     Abstract available


  112. VAJGEL G, Correia MRB, Costa CLC, Sette LH, et al
    Nephrology pictures: pemphigus vulgaris and membranous nephropathy.
    J Nephrol. 2021 Oct 15. pii: 10.1007/s40620-021-01151.
    PubMed    


  113. GUO W, Tan PH, Baikunje S
    Membranous nephropathy in a patient with COVID-19 infection.
    J Nephrol. 2021 Oct 7. pii: 10.1007/s40620-021-01165.
    PubMed    


  114. JARRICK S, Lundberg S, Stephansson O, Symreng A, et al
    Pregnancy outcomes in women with immunoglobulin A nephropathy: a nationwide population-based cohort study.
    J Nephrol. 2021;34:1591-1598.
    PubMed     Abstract available


    September 2021
  115. MASSET C, Renaudin K, Kervella D, Chapelet A, et al
    Collapsing glomerulopathy in a patient with APOL1 intermediate-risk genotype triggered by lupus nephritis and SARS-CoV-2 infection: lessons for the clinical nephrologist.
    J Nephrol. 2021 Sep 24. pii: 10.1007/s40620-021-01144.
    PubMed    


    July 2021
  116. LUAN R, Tian G, Zhang H, Shi X, et al
    Urinary exosomal circular RNAs of sex chromosome origin are associated with gender-related risk differences of clinicopathological features in patients with IgA nephropathy.
    J Nephrol. 2021 Jul 22. pii: 10.1007/s40620-021-01118.
    PubMed     Abstract available


  117. KANT S, Arend LJ, Gapud E, Seo P, et al
    Characterization of interstitial infiltrates in MPO and PR3 anti-neutrophil cytoplasmic antibody glomerulonephritis.
    J Nephrol. 2021 Jul 20. pii: 10.1007/s40620-021-01126.
    PubMed     Abstract available


    June 2021
  118. GEETHA D, Attarwala N, Zhang C, Kant S, et al
    Serum and urinary metabolites discriminate disease activity in ANCA associated glomerulonephritis in a pilot study.
    J Nephrol. 2021 Jun 28. pii: 10.1007/s40620-021-01095.
    PubMed     Abstract available


  119. BINET Q, Aydin S, Lengele JP, Cambier JF, et al
    Lessons for the clinical nephrologist: an uncommon cause of pulmonary-renal syndrome.
    J Nephrol. 2021;34:935-938.
    PubMed     Abstract available


    May 2021
  120. NAGAI M, Kobayashi N, Izumi N, Ohbayashi T, et al
    Pre-treatment hematuria and crescents predict estimated glomerular filtration rate trajectory after methylprednisolone pulse therapy with tonsillectomy for IgA nephropathy.
    J Nephrol. 2021 May 20. pii: 10.1007/s40620-021-01064.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.